Related references
Note: Only part of the references are listed.Prognostic and predictive biomarkers in breast cancer: Past, present and future
Andrea Nicolini et al.
SEMINARS IN CANCER BIOLOGY (2018)
Prognostic values of the mRNA expression of natural killer receptor ligands and their association with clinicopathological features in breast cancer patients
Ali Abouelghar et al.
Oncotarget (2018)
Signals Controlling Lytic Granule Polarization at the Cytotoxic immune Synapse
Anna Kabanova et al.
FRONTIERS IN IMMUNOLOGY (2018)
CD56+immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changes
Daniel Kerekes et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
M. J. Duffy et al.
EUROPEAN JOURNAL OF CANCER (2017)
MicroRNA-519a-3p mediates apoptosis resistance in breast cancer cells and their escape from recognition by natural killer cells
Christian Breunig et al.
CELL DEATH & DISEASE (2017)
Immunosurveillance and Immunoediting of Breast Cancer via Class I MHC Receptors
Megan M. Tu et al.
CANCER IMMUNOLOGY RESEARCH (2017)
NK-92: an 'off-the-shelf therapeutic' for adoptive natural killer cell-based cancer immunotherapy
Garnet Suck et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival
Sabrina Genssler et al.
ONCOIMMUNOLOGY (2016)
Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells
Heleen H. Van Acker et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Targeting natural killer cells in cancer immunotherapy
Camille Guillerey et al.
NATURE IMMUNOLOGY (2016)
Natural Killer Cells for immunotherapy-Advantages of the NK-92 Cell Line over Blood NK Cells
Hans Klingemann et al.
FRONTIERS IN IMMUNOLOGY (2016)
Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain
Se Jeong Lee et al.
BMC CANCER (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Natural killer T cell activation overcomes immunosuppression to enhance clearance of postsurgical breast cancer metastasis in mice
Simon Gebremeskel et al.
ONCOIMMUNOLOGY (2015)
Effect of tumor cells and tumor microenvironment on NK-cell function
Massimo Vitale et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Human NK cells: from surface receptors to the therapy of leukemias and solid tumors
Lorenzo Moretta et al.
FRONTIERS IN IMMUNOLOGY (2014)
Intratumoral treatment of smaller mouse neuroblastoma tumors with a recombinant protein consisting of IL-2 linked to the Hu14.18 antibody increases intratumoral CD8+T and NK cells and improves survival
Richard K. Yang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
A cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine model
Shicheng Yang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
NK cell-based immunotherapy for malignant diseases
Min Cheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Treatment of patients with advanced cancer with the natural killer cell line NK-92
Torsten Tonn et al.
CYTOTHERAPY (2013)
Cellular therapy of cancer with natural killer cells-where do we stand?
Hans G. Klingemann
CYTOTHERAPY (2013)
CD56 marks human dendritic cell subsets with cytotoxic potential
Dessie Roothans et al.
ONCOIMMUNOLOGY (2013)
Receptor Signaling Clusters in the Immune Synapse
Michael L. Dustin et al.
ANNUAL REVIEW OF BIOPHYSICS, VOL 41 (2012)
A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study)
C. Sebban et al.
EUROPEAN JOURNAL OF CANCER (2012)
Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model
Brenna E. Swift et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
BREAST CANCER HER2-a good addiction
Lisa A. Carey
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Biological role of NK cells and immunotherapeutic approaches in breast cancer
Maria P. Roberti et al.
FRONTIERS IN IMMUNOLOGY (2012)
IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect
Don M. Benson et al.
BLOOD (2011)
Human Breast Tumor Cells Induce Self-Tolerance Mechanisms to Avoid NKG2D-Mediated and DNAM-Mediated NK Cell Recognition
Emilie Mamessier et al.
CANCER RESEARCH (2011)
Activating and inhibitory receptors of natural killer cells
Hollie J. Pegram et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
Emilie Mamessier et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma
Wendy Anne Boivin et al.
LABORATORY INVESTIGATION (2009)
Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
S. Arai et al.
CYTOTHERAPY (2008)
Universal expression of cell adhesion molecule NCAM in neuroblastoma in contrast to L1: implications for different roles in tumor biology of neuroblastoma?
Robin Wachowiak et al.
PEDIATRIC SURGERY INTERNATIONAL (2008)
Formation and function of the lytic NK-cell immunological synapse
Jordan S. Orange
NATURE REVIEWS IMMUNOLOGY (2008)
Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo
Md. Zahidunnabi Dewan et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Activation-induced expression of CD56 by T cells is associated with a reprogramming of cytolytic activity and cytokine secretion profile in vitro
Jane Kelly-Rogers et al.
HUMAN IMMUNOLOGY (2006)
Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells
YT Bryceson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis
L Moretta et al.
IMMUNOLOGY LETTERS (2005)
Telomerase: regulation, function and transformation
CK Dong et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
Molecular mechanisms of NCAM function
AM Hinsby et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
Ex vivo expansion of natural killer cells for clinical applications
HG Klingemann et al.
CYTOTHERAPY (2004)
The mature activating natural killer cell immunologic synapse is formed in distinct stages
JS Orange et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
What does it take to make a natural killer?
F Colucci et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Ex vivo expansion of the highly cytotoxic human natural killer cell line NK-92 under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy
YK Tam et al.
CYTOTHERAPY (2003)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Calcein-acetyoxymethyl cytotoxicity assay: Standardization of a method allowing additional analyses on recovered effector cells and supernatants
S Neri et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2001)
Cellular immunotherapy of malignancies using the clonal natural killer cell line NK-92
T Tonn et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2001)
Ex vivo purging of stem cell autografts using cytotoxic cells
G Maki
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2001)
Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92
G Maki et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2001)
Share Paper
